In May possibly 2019, a trial at Nanjing College Healthcare facility commenced evaluating dapagliflozin to liraglutide, and also to the anti-diabetic medication acarbose, for his or her respective consequences on cognitive and olfactory functionality in 87 overweight men and women whose Kind 2 diabe